Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Influenza A pneumonia].

R P Veenstra1, C C Boelen, J G Zijlstra

  • 1Afd. Interne Geneeskunde, Academisch Ziekenhuis, Groningen.

Nederlands Tijdschrift Voor Geneeskunde
|October 26, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Population Pharmacokinetic Model and Optimal Sampling Strategies for Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis.

Antimicrobial agents and chemotherapy·2022
Same author

The impact of changing toward higher welfare broiler production systems on greenhouse gas emissions: a Dutch case study using life cycle assessment.

Poultry science·2022
Same author

Reply to Van Daele et al., "Fluconazole Underexposure in Critically Ill Patients: a Matter of Using the Right Targets?"

Antimicrobial agents and chemotherapy·2021
Same author

Optimization of Fluconazole Dosing for the Prevention and Treatment of Invasive Candidiasis Based on the Pharmacokinetics of Fluconazole in Critically Ill Patients.

Antimicrobial agents and chemotherapy·2020
Same author

Effectiveness of a Tailored Work-Related Support Intervention for Patients Diagnosed with Gastrointestinal Cancer: A Multicenter Randomized Controlled Trial.

Journal of occupational rehabilitation·2020
Same author

Tijdschrift voor kindergeneeskunde·2020
Same journal

[Insulin intoxications caused by falsified semaglutide].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[Professional skepticism in medical research].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[Improving mobility in painful osteoarthritis].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[The effectiveness and costs of the Back At work After Surgery (BAAS) work-integrated care pathway on return to work for patients receiving knee arthroplasty].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[The rise of genetic therapies: urgent moral and societal questions].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[A man with a wound on his elbow].

Nederlands tijdschrift voor geneeskunde·2026
See all related articles

Primary influenza A pneumonia is a rare but severe complication. Early recognition is crucial for timely treatment with antiviral medications like neuraminidase inhibitors, improving patient outcomes.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Virology

Background:

  • Influenza typically causes mild illness, but severe complications like pneumonia can occur.
  • Secondary bacterial pneumonia is a known complication, but primary viral pneumonia is less common.
  • Primary influenza viral pneumonia presents with severe respiratory distress and has a high mortality rate.

Observation:

  • Three cases of primary influenza A pneumonia were diagnosed in a 74-year-old man and two neonates (11 months and 4 weeks old).
  • Influenza A virus was isolated from sputum in the two infant patients.
  • Two of the three patients, including the elderly man and the youngest infant, did not survive despite intensive care.

Findings:

  • Primary influenza A pneumonia is a distinct and severe clinical entity.

Related Experiment Videos

  • This complication affects both elderly and very young patients.
  • The condition is associated with a high fatality rate.

    • Implications:

    • Early clinical recognition of primary influenza pneumonia is vital for prompt intervention.
    • Antiviral therapies, such as neuraminidase inhibitors, offer potential treatment avenues.
    • Increased awareness among clinicians can improve management and outcomes for this severe influenza complication.